Jiangxi Fushine Pharmaceutical Co.,Ltd. Posted 164.2 Million Yuan Net Loss in 2022

Jiangxi Fushine Pharmaceutical Co.,Ltd. (江西富祥药业股份有限公司) (300497.SZ) reported a net loss of 164.2 million yuan in 2022, reversing a net profit of 39.5 million yuan for the previous year.

Meanwhile, the company posted 1.6 billion yuan in revenue, up 15.2% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 2.4 billion yuan in total liabilities, with a liability-to-asset ratio of 46.8%.